« Study: Cholesterol drug lowers blood clot risk – Boston Globe | Home | Filtering Out Bad Cholesterol (HealthCentral) »
Abbott, Astra drug combo works in cholesterol study – Forbes
By fthomas | March 29, 2009
ORLANDO, Fla, March 29 (Reuters) – A combination of Abbott Laboratories (nyse: ABT – news – people )’ new TriLipix triglycerides medicine and a low dose of AstraZeneca Plc (nyse: AZN – news – people )’s Crestor cholesterol drug proved better than the …
Topics: High Cholesterol | No Comments »